Co-Authors
This is a "connection" page, showing publications co-authored by Annabelle Volgman and Tisha Suboc.
Connection Strength
2.163
-
Lessons Learned from Coronavirus Disease 2019 Sex Disparities. J Womens Health (Larchmt). 2021 04; 30(4):453-454.
Score: 0.764
-
End-Of-Life Care for Patients With End-Stage Heart Failure, Comparisons of International Guidelines. Am J Hosp Palliat Care. 2024 Jan; 41(1):87-98.
Score: 0.217
-
Editorial commentary: COVID-19 as a cardiovascular disease risk factor. Trends Cardiovasc Med. 2022 11; 32(8):476-478.
Score: 0.209
-
Hyperdynamic left ventricular ejection fraction is associated with higher mortality in COVID-19 patients. Am Heart J Plus. 2022 Feb; 14:100134.
Score: 0.205
-
The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients. Cardiovasc Pathol. 2021 Nov-Dec; 55:107374.
Score: 0.196
-
Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19. Am Heart J Plus. 2021 Apr; 4:100022.
Score: 0.194
-
Sex Differences in Takotsubo Syndrome: A Narrative Review. J Womens Health (Larchmt). 2020 08; 29(8):1122-1130.
Score: 0.172
-
Clinical outcomes of COVID-19 infection in patients with pre-existing cardiovascular disease. Am Heart J Plus. 2022 Aug; 20:100189.
Score: 0.052
-
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19. J Am Heart Assoc. 2022 09 20; 11(18):e025198.
Score: 0.052
-
Prognostic value of H2FPEF score in COVID-19. Am Heart J Plus. 2022 Jan; 13:100111.
Score: 0.051
-
Cardiovascular findings on chest computed tomography associated with COVID-19 adverse clinical outcomes. Am Heart J Plus. 2021 Nov; 11:100052.
Score: 0.050